Replies to post #440850 on Anavex Life Sciences Corp (AVXL)

[Pazzo1212]

The only change I would make is the number of outstanding shares. In 5-10 years they will have many more employees, a larger research dept, etc. and you should be safe to at least double the outstanding shares to 200-250k shares.

Still a grand slam, but more realistic…

[WilliamMunny]

Falconer, putting aside the contemplation of that juicy dividend for a moment, what might be the first indication that A3-71 (or blarcamesine) may markedly and safely slow normal aging processes in neurons and other cells or tissues? Would you not think that Missling, being a very clever fellow (IMO), would undertake a pre-clinical trial on murines, which would not take very long if started half way (or even a third of the way) through the rodents' lives. In fact, I believe it wouldn't be unreasonable to think that he may have started such a trial already...

[Bourbon_on_my_cornflakes]

What If An Anavex Drug Gets Widely Used?

Since this is just entertainment, don't get upset that certain of your assumptions are preposterous IMHO.

If the preservative effects were to occur, $1 a day would be silly. $10 minimum given inflation. So $1.82 trillion revenues instead of $182 billion. Figure 50% goes to taxes and actual cost of manufacturing and distribution. So that leaves $910 billion. Maybe $90 billion could be productive spent on new drug research. So $820 billion to distribute each year. A nice round $10,000 a share dividend. Assuming a generous 5% to 10% yield, that imply a share price of $100,000 to $200,000 a share.

For the larger shareholders here that might get them on the Forbes 400, LOL

Of course, right now I'd love to see this hit $130 so I could retire.